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Abstract
Background: Current evidence supports the use of exercise-based treatment for chronic low back pain that
encourages the patient to assume an active role in their recovery. Walking has been shown it to be an acceptable
type of exercise with a low risk of injury. However, it is not known whether structured physical activity
programmes are any more effective than giving advice to remain active.
Methods/Design: The proposed study will test the feasibility of using a pedometer-driven walking programme, as
an adjunct to a standard education and advice session in participants with chronic low back pain. Fifty adult
participants will be recruited via a number of different sources. Baseline outcome measures including self reported
function; objective physical activity levels; fear-avoidance beliefs and health-related quality of life will be recorded.
Eligible participants will be randomly allocated under strict, double blind conditions to one of two treatments
groups. Participants in group A will receive a single education and advice session with a physiotherapist based on
the content of the ‘Back Book’. Participants in group B will receive the same education and advice session. In
addition, they will also receive a graded pedometer-driven walking programme prescribed by the physiotherapist.
Follow up outcomes will be recorded by the same researcher, who will remain blinded to group allocation, at
eight weeks and six months post randomisation. A qualitative exploration of participants’ perception of walking will
also be examined by use of focus groups at the end of the intervention. As a feasibility study, treatment effects
will be represented by point estimates and confidence intervals. The assessment of participant satisfaction will be
tabulated, as will adherence levels and any recorded difficulties or adverse events experienced by the participants
or therapists. This information will be used to modify the planned interventions to be used in a larger randomised
controlled trial.
Discussion: This paper describes the rationale and design of a study which will test the feasibility of using a
structured, pedometer-driven walking programme in participants with chronic low back pain.
Trial Registration: [ISRCTN67030896]
Background
Low back pain (LBP) has a high lifetime prevalence with
non-specific LBP representing the large majority of
cases [1]. Relapses in pain (60%) and work absences
(33%) are common [1] leading it to be one of the most
costly conditions in the UK (total cost of £stg10,668
million) [1]. Current research evidence supports the use
of exercise-based treatment programmes for chronic
LBP (CLBP pain persisting for at least 12 weeks) that
encourage the patient to assume an active role in their
recovery [2]. Although the European Guidelines have
advocated exercise as the first line of treatment in the
management of CLBP it is not clear which type of exer-
cise works best or what the ‘active ingredient’ of exercise
therapy is. Therefore, it has been suggested that much
more research is required to allow the development of a
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wider range of low cost, but effective exercise pro-
grammes [1].
There is however a significant challenge in encoura-
ging people with CLBP to become more physically
active as this group often exhibit fear avoidance beha-
viour, resulting in decreased physical activity (PA), in
the belief that this will limit exacerbations in their LBP
[3]. However given the evidence for the benefit of regu-
lar exercise in people who cope with their CLBP,
approaches that encourage and motivate long-term
lifestyle changes in PA are required [4]. A Cochrane
review of interventions that promote PA concluded that
a mixture of professional guidance, self-direction and
on-going professional support can encourage adults to
be more physically active [5]. One type of intervention
that has been shown to be effective in increasing PA
and which incorporates these aspects is pedometer-
driven walking [6].
Walking is an ideal intervention for physically inactive
individuals. In previous research, we have shown it to be
a very acceptable type of exercise [7], as it does not
require training or equipment and can be undertaken in
an individual’s own locality and time [8], with little risk
of injury in sedentary, healthy individuals [9]. Recent
walking initiatives, such as Walking the Way to Health
Initiative and the National Step-O-Meter campaign
http://www.whi.org.uk have been advocated by the
Chartered Society of Physiotherapy [10]. The Step-O-
Meter campaign has focused on the recommendation
that individuals should accumulate 10,000 steps per day
[11], using pedometers to set goals and record compli-
ance [12]. Pedometers are simple to use, inexpensive
devices which produce a user-friendly output (steps/
day). A recent meta-analysis has shown they are effec-
tive motivators to taking more activity and lead to
health improvements (reduction in blood pressure and
body mass index (BMI)) [13]. However, these findings
need to be extended from healthy sedentary middle-
aged adults to patient groups.
In the UK, anecdotal evidence suggests that people
with CLBP can reduce their pain through walking, and
practitioners are being encouraged to loan pedometers
in order to increase PA [10]. However, there is little evi-
dence to guide this practice. Only one published study
has investigated walking (unsupervised or monitored),
the outcomes of which were less effective than those fol-
lowing physiotherapy or exercise therapy [14] and
another trial is ongoing [15]. In contrast one study (of
chiropractic versus medical management) suggested that
those engaged in additional unsupervised brisk walking
(>3 hours per week) had a better outcome [16]. Limited
conclusions can be drawn from these studies as partici-
pants did not receive a structured walking programme.
Therefore, given that there are no previous trials of the
use of pedometers in CLBP; research is required so that
guidelines can be drawn up on how best to implement
this type of programme.
It is not known whether this type of structured and
tailored motivational programme is likely to be more
effective than simply giving the patient advice to remain
active and promoting self-management strategies via an
educational booklet. Such booklets (e.g. the Back Book
[17]), which are recommended by both the American
and European Guidelines [18,1], have been shown to be
similar or only slightly inferior in effectiveness to cost-
lier interventions (physiotherapy, supervised exercise
classes, yoga, spinal manipulation, acupuncture and
massage) [17,19].
Aim
The aim of the study is to test the feasibility of using a
structured, pedometer-driven walking programme, as an
adjunct to a standard education and advice session in
patients with CLBP. This work will add to ongoing
research in this area by some of the team [15].
Specific objectives are as follows
i. To assess recruitment and adherence rates in educa-
tion and advice and education and advice plus walking
programme groups.
ii. To determine the incidence of adverse events,
including musculo-skeletal injuries, and level of overall
satisfaction in both groups.
iii. To conduct a qualitative exploration of partici-
pants’ experience of the walking plus education group.
iv. To make between and within group comparisons
and estimate effect sizes for change in functional disabil-
ity, PA levels, stage of change, fear-avoidance, self-
efficacy, health-related quality of life, psychosocial
beliefs, general health and participant satisfaction.
Methods/Design
Design
Single-blinded feasibility study.
Ethical approval
Ethical approval for the trial has been granted by The
Office for Research Ethics Committees (Northern
Ireland) [Ref No. 09/NIR01/49]. All patients who agree
to take part will be required to give informed written
consent prior to participation in the study.
Study population
50 adult participants (Male or Female; aged 18 years or
over) with LBP persisting for at least twelve weeks will
be included in the study. Participants will be recruited
through a number of different sources using previously
employed methods [20].
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Identification of potential participants and screening
procedures
In order to maximise recruitment and to ensure that the
sample size is achieved, potential participants will be
identified from a number of sources.
I) The Physiotherapy department at the Robinson
Memorial Hospital, Ballymoney will serve as one recruit-
ment source. Potential participants will be identified
from the referral lists and sent a letter inviting them to
take part in the research study. This letter will state
clearly that the individual is under no obligation to take
part in the study and that non-participation will not
prevent them from still receiving a standard physiother-
apy appointment after the 9-13 week waiting list. The 8
week intervention period of the study therefore fits
within this timescale. Interested participants will contact
the Physiotherapy department to arrange an initial
appointment time. They will then be sent a confirmation
letter and information sheet which will allow for a ‘cool-
ing off’ period of approximately one week.
II) Retrospective searches of computerised records of
local General Practices will be conducted by practice
staff with the assistance of the Clinical Trials Practi-
tioner (CTP) from the Northern Ireland Primary Care
Research Network (PCRN). Potential participants will be
sent an invitation letter and information sheet from the
study team along with a covering letter from their GP.
Potential participants will be asked to complete an
enclosed reply slip indicating their interest in being con-
tacted by a member of the research team with a view to
taking part in the study. They will also have the oppor-
tunity to indicate that they are not interested in the
study and do not wish to be contacted further using the
same reply slip. Potential participants who do not return
the reply slip will also be followed up by a telephone
call from the CTP at least two weeks after the invitation
letter was sent. No further contact will be made after
this stage with individuals who indicate that they do not
wish to take part. Those who do respond positively to
the invitation letter or telephone call from CTP will
then be contacted separately by telephone and screened
for eligibility by a member of the local research team.
Those meeting the inclusion criteria will then be sent a
second letter with an appointment time arranged for
approximately one week after telephone screening. This
is in order to allow an adequate ‘cooling-off’ period dur-
ing which the individual can fully consider their partici-
pation in the study.
III) A third potential source for recruitment will be
identification of participants via Occupational Health or
via email/poster advertisements to staff and students at
the University of Ulster.
At the first appointment, a full verbal explanation of
the study procedures will be provided and eligibility to
participate confirmed using the inclusion and exclusion
criteria shown in table 1. Written informed consent will
then be sought from eligible participants. At this stage a
final exclusion criteria will be applied. Apparently eligi-
ble participants will be fitted with an activPAL physical
activity monitor (PAL Technologies, Glasgow, UK) for
one week. This is in order to provide an objective mea-
surement of PA levels and to confirm that the individual
does not have a pre-existing high level of PA. This will
be determined according to previously defined daily step
count categories [11]. To meet the final criteria for elig-
ibility, the individual must be taking less than an average
of 8,500 steps/day. Participants meeting the criteria
outlined above will then be invited back one week later
to begin the intervention period of the study. Details of
the recruitment, screening and study procedures are
outlined in Additional file 1. Participants recruited via
method I will receive the intervention in the
Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
Males and females aged 18 years or over Any spinal surgery in the past twelve months
LBP with/without radiation persisting for greater than 12
weeks.
Evidence of nerve root, spinal cord, or cauda equina compression, severe spinal
stenosis indicated by signs of neurogenic claudication, Grade 3-4 spondylolisthesis,
(Grade 1-2 spondylolisthesis eligible for inclusion) fibromyalgia or systemic/
inflammatory disorder
Capable of participating in home based exercise as indicated
by their GP [home based, walking intervention]
Any other current musculoskeletal injury or contraindication to increasing physical
activity levels, including any cardio-respiratory or other medical condition limiting
exercise tolerance
Fluency in English (verbal and written) Any history of epilepsy
LBP caused by involvement in a road traffic accident in the last 12 months or
ongoing litigation
History of serious Psychological or Psychiatric illness (mild depression eligible for
inclusion)
Current Pregnancy
High activity levels categorised according to objective physical activity levels (7 day
ActivPAL recording)
McDonough et al. BMC Musculoskeletal Disorders 2010, 11:163
http://www.biomedcentral.com/1471-2474/11/163
Page 3 of 8
Physiotherapy department while participants recruited
via methods II and III will receive the intervention in
the research centre at the University of Ulster.
Baseline outcome measurements
Baseline recording of all outcome measures shall be car-
ried out by the same researcher prior to randomisation.
Outcome Measures
Primary outcome
Functional disability This will be assessed using the
Oswestry Disability Questionnaire (ODQ). This has
been shown to be a valid and reliable measure of pain
and physical function in LBP patients [21]. The ODQ
consists of 10 sections, each with six levels (with a maxi-
mum score in each section of five points) that assess the
individual’s limitations in various activities of daily
living. The sum of all 10 sections is divided by the total
possible score and the result multiplied by 100 to gener-
ate a percentage score. Values range from 0 (best health
state) to 100 (worst health state) with an average score
of 43% identified for chronic back pain participants
[21-23]. A minimum important change of between
10-12 points over time, or an improvement from base-
line of between 20-30% for an individual patient has
been recommended [24].
Secondary outcomes
PA Level Objective change in PA levels will be mea-
sured using an activPAL™ professional physical activity
logger (PAL Technologies, Glasgow, UK). The activPAL
is a small device (5 × 3 cm) containing a uni-axal accel-
erometer which provides a valid and reliable measure of
steps taken, cadence and time spent lying/sitting, stand-
ing and stepping under free-living conditions. Reported
ICCs for inter-device reliability range from 0.79-0.97
(CIs not stated) [25]. The monitor will be attached to
the participant’s anterior thigh using PALstickies™ and
reinforced with Vulcan fixation tape (Mobilis Healthcare
Group Limited, Oldham, Lancashire, UK). The device
will be worn for seven consecutive days at each time-
point (baseline, eight weeks and 24 weeks). Each partici-
pant will also complete the IPAQ (short form) at each
time point [26]. The IPAQ asks the participant about
the time they spent being physically active in the last
seven days.
Stage of Change Readiness to change will be assessed
using a standardised questionnaire, which describes an
individual’s position in a cycle of change described
within the Prochaska and Diclemente framework [27].
Fear-Avoidance Beliefs - Physical Activity Assessed
using the Fear-Avoidance Beliefs Questionnaire (FABQ):
The FABQ is a 16 item self-report questionnaire that
specifically focuses on participants’ beliefs about how
PA and work affect their low back pain [28]. Only the
PA items will be recorded. This method has previously
been employed in other CLBP studies [20,29].
Back Beliefs questionnaire (BBQ) The primary objec-
tive of the BBQ is to assess the individual’s beliefs about
various aspects of the future as a consequence of LBP.
The scale comprises nine inevitability statements, along
with five statements used as distracters. The scale is cal-
culated by reversing and summing the 9 inevitability
measure scores. The scale has been shown to have good
internal validity (Chronbach’s Alpha = 0.70) and reliabil-
ity (Intraclass Correlation Coefficient = 0.87) [30].
Physical Activity Self-efficacy Scale Self-efficacy was
assessed using the five point scale proposed by Marcus
et al [31]. Perceived self-efficacy is described as the
belief or the confidence in owns own ability to perform
a behaviour necessary to reach a desired goal or achieve
an expected outcome[32]. Self efficacy is regarded as an
important factor in the self-management of chronic con-
ditions and is highly correlated with disability [33].
Pain Pain will be assessed using a numerical rating scale
(0-10). Participants will be instructed to select a number
between 0 and 10 that best describes their pain over the
last seven days with 0 meaning ‘No pain’ and 10 mean-
ing the ‘Worst pain imaginable’ [24].
Health-related quality of life This will be measured
using the EuroQol-5D [34], a self-administered ques-
tionnaire that assesses the participant’s health-related
quality of life using a core set of five health-related
quality of life items [35]. Its validity and reliability are
supported, and it has been recommended for use in low
back pain research [36]. For the UK population, an aver-
age weighted health index of 0.86 and self-rated health
status of 82.48 have been reported in the literature [37].
Use of this outcome along with the information col-
lected on use of health care resources will facilitate a
cost-utility analysis of the trial interventions.
Health Care Usage This will be assessed using a ques-
tionnaire developed by members of the research team
in conjunction with a Health Economist. This tool
has successfully been employed during a previous
study [20].
Global Rating of change for physical activity [38]. At
baseline participants will be asked to rate their ability to
be more physically active compared to the previous
week. This will be recorded as No change, Worse or
Better. If they answer Worse or Better, they will be
asked to indicate how much it is worse or better using
one of the following markers: A tiny bit - almost the
same; A little bit; Somewhat; Moderately; Quite a bit, A
great deal or A very great deal. They will also be asked
to rate how important this change or lack of change is
to them using the same markers. At each follow up
assessment, participants will be asked to give a rating
compared to the last time point.
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Prior to randomization, each participant’s preference
for which treatment they would like to receive will be
recorded. Expectations of assigned treatment will also
be recorded using a Likert Scale [20]. On completion of
the trial a participant satisfaction questionnaire will be
administered to ascertain views on the interventions and
perception of benefit [20].
Treatment allocation
A statistician who will have no contact with the day to
day running of the study shall carry out all aspects of pre-
paration for group randomisation. A randomisation
sequence will be generated using computer software with
an allocation ratio of 1:2. This is order to ensure more
information can be gathered on the walking intervention
group (Group B). This is relevant since we wish to gather
as much detail as possible regarding adverse events or
other side effects and will enable us to learn more about
the type and level of training required for this interven-
tion in a fully powered trial. Blank cards will be printed
with Group A (Education and advice) or Group B (Edu-
cation and advice plus a structured walking programme).
These cards will be placed inside sequentially numbered
opaque sealed envelopes. Following baseline assessment,
these envelopes will be used to assign participants in
sequence to one of the two treatment groups (Group A
or Group B). Participants will therefore be randomised
under strict double-blind conditions.
Treatment protocols
Education & advice (Group A)
Participants in the Education and advice group will
receive a single, one to one session with a physiothera-
pist who will complete a physical examination and give
standardised advice using the ‘Back Book’ [17]. The aim
of the session will be to encourage a graded return to
normal activities. Specifically the session will address the
causes of low back pain, as well as giving advice on how
to deal with an attack of back pain, the nature of
chronic pain and how to better cope with these issues.
All participants will be given a copy of the Back Book to
keep. This will have a contact telephone number for the
physiotherapist printed on the inside of the front cover.
Participants will be encouraged to contact the phy-
siotherapist to seek advice or address any further ques-
tions that they may have at a later date during the
intervention period. If they wish the participants can
leave a message for the physiotherapist who will call
them back using a standardised telephone script adapted
from a previous study [20].
Education & advice plus a structured walking programme
(Group B)
Participants in Group B will receive the same single
education and advice session as described above for
group A. In addition, they will also receive a graded
pedometer-driven walking programme prescribed by the
physiotherapist. Each participant will be given a ped-
ometer (Yamax Digiwalker CW-701, Yamax, Japan) to
monitor their activity. This has been shown to be the
most reliable, commercially obtainable pedometer which
is currently available [39]. Participants will have the ped-
ometer for a one week familiarisation period before they
return for their next appointment. At this appointment
the specific content of the tailored intervention will
begin. This will be determined according to the 5A’s
model of health behaviour advice. This model was
developed for brief smoking cessation advice but has
also been proposed as a tool by which clinicians work-
ing in a primary care setting might provide advice
aimed at influencing other health related behaviours,
including PA [40]. The 5A’s are as follows: Ask, Assess
willingness to change, Advise, Assist, and Arrange
follow-up. During the study the model will therefore be
applied in treatment group B according to the following
format.
1) Ask: Participants will be asked about their current
PA and exercise history. 2) Assess: Participants current
level of motivation to exercise will be measured using
the readiness to change questionnaire which will have
been recorded at baseline. Individuals in pre-contempla-
tion will be asked their reasons for taking part in the
trial and their barriers to further activity. They will then
be asked how they feel about their exercise levels and if
they are willing or ready to try a bit more. 3) Advise:
Participants will be given further advice on the benefits
of PA for their back pain. This will be delivered using
personalised but non-judgmental language. This will be
based on the participant’s responses to question 1 and
will make reference to the information in the ‘Back
Book’. 4) Assist: Participants will be given additional
advice which will include an explanation of the use of
pedometers to set individual goals and how this may be
used to maintain motivation. There will then be a 10
minute self-efficacy walk, during which the participant
will wear the pedometer while the physiotherapist will
discuss aspects of walking as a form of PA (such as foot-
wear and safety) as well as reinforcing some of the pre-
viously discussed aspects of the intervention. This will
be followed by a brief discussion during which an initial,
weekly step goal will be determined by negotiation. This
will be set using the Goal Attainment Scale (GAS). This
is order to place the step goal in a context which relates
to the participants own circumstances. Participants will
be asked to rate their perception of the likelihood of
achieving the weekly goal on a scale of 0-10. If they rate
the scale as below 8, the target will then be re-
negotiated in order to reach a target which is seen as
realistic by both the physiotherapist and participant.
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Lastly, the physiotherapist will demonstrate how to
record daily step counts and any adverse events in a
diary. This will also be used to determine compliance
which will be based on the participants self-reported
weekly step counts and recorded by the physiotherapist
as a percentage of the target number of steps completed.
5) Arrange follow-up: Appropriate follow-up and sup-
port will then be arranged. This will involve a discussion
of a follow-up date or time frame to assess progress, to
assist in overcoming difficulties and to reassess daily
step goals. To encourage compliance, participants will
receive a weekly telephone call from a physiotherapist
using a pre-determined script (approximately 10-15
minutes). During this conversation, difficulties will be
addressed, data from the pedometer recorded and a new
walking goal set. This approach has been previously
employed in other walking intervention studies [41]. In
addition, participants will be encouraged to contact the
physiotherapist if they have any other questions or con-
cerns at any other time during the intervention period.
The specific features of the five components will be
recorded for each participant in a standardised manner.
Follow-up procedure
Follow up measurements of all outcome measurements
will be recorded at eight weeks (on completion of trial)
and at six months after randomisation into the trial by a
member of the research team who shall remain blinded
to group allocation throughout the study.
Focus Groups
Qualitative exploration of individuals’ perception of walk-
ing will also be examined by use of focus groups at the
end of the intervention. Participants in group B will be
invited to one of three to five groups, consisting of
between 5 and 8 participants, to discuss their experiences,
expectations and satisfaction with the walking programme.
Each focus group will consist of a maximum of eight parti-
cipants and will take place over a two-hour period. A ‘clue
and cue process’, using a checklist of topics, will be used
to ensure that the same basic areas are covered, but allow-
ing any issues of importance to emerge. Sessions will be
moderated by an experienced, independent focus group
moderator who will have had no previous contact with
study participants prior to the focus group meetings.
Audio-tape recordings and field notes will be prepared by
another member of the research team not involved in the
running of the trial. Interviews will be transcribed, and
interpretation, synthesis and data reduction undertaken
independently by two members of the research team. Ana-
lysis will then be undertaken using qualitative research and
data analysis software (N-VIVO [QDSR]). The findings
will be presented to participants and therapists for their
feedback and to help inform further research.
Sample size
No formal sample size calculation will be carried out. As
a feasibility study, we aim to recruit a total sample of 50
participants (Approximately 17 in Group A and 33 in
Group B according to the 1:2 randomisation methods).
This sample size reflects both a realistic target for the
intervention period and one which we anticipate will
provide sufficient information on the interventions to
inform future studies. In particular, we are interested in
gathering as much information as possible on any
adverse events (including minor musculoskeletal inju-
ries) associated with the walking intervention. Two
reported adverse events in the walking group will repre-
sent an approximate incidence of 5%.
Statistical analysis
As a feasibility study, significance tests will not be per-
formed or reported for the primary or secondary out-
comes. Treatment effects will be represented by point
estimates and confidence intervals. The assessment of
participant satisfaction will be tabulated, as will adher-
ence levels and any recorded difficulties or adverse
events experienced by the participants or therapists.
This information will be used to modify the planned
interventions to be used in the main RCT. The follow-
ing criteria would suggest that a main trial is not feasi-
ble: no apparent change in the outcomes with
confidence intervals that include large negative values,
feedback from participants that they were unable to
complete (or lack of adherence with) the walking pro-
gramme and/or unable to use the pedometers; high
levels of musculoskeletal injuries occurring.
Adverse event recording
Any adverse events will be reported using a standard
proforma.
Service user involvement
Two service users will sit on the research team panel
during the developmental and running stages of the
study.
Training requirements
Both service users will attend two separate training
sessions at the research centre to familiarise themselves
with the study procedures. In addition, all physiothera-
pists involved in delivering the interventions will receive
a standardised period of training prior to commence-
ment of the study.
Discussion
This paper describes the rationale and design of a study
which will test the feasibility of using a structured, ped-
ometer-driven walking programme in participants with
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CLBP. This study will be to provide important practical
information on pedometer prescription for physiothera-
pists and people with CLBP. The longer-term objective
is to provide the ground work necessary for a main trial
to establish whether the use of such initiatives are more
effective than simply giving advice to be more active.
Additional material
Additional file 1: Participant flow diagram. This file describes the 3
recruitment routes and the interventions received in each group.
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